Unihealth Hospitals Limited deploys Rs 8.31 crore to UMC Hospitals
Key highlights
- Unihealth Hospitals received Rs 8.31 crore from preferential warrants by September 30, 2026.
- UMC Hospitals received and utilized the full Rs 8.31 crore for capex and working capital by September 30, 2026.
- Unihealth Hospitals reported no deviation or variation in use of the preferential-issue proceeds.
- The Rs 2.11 crore corporate-purpose allocation had nil proceeds and nil utilization at September 30, 2026.
powered by IRIS

Unihealth Hospitals Limited deployed the full Rs 8.31 crore received from its preferential convertible-warrant issue to UMC Hospitals Private Limited by September 30, 2026, for hospital capital expenditure and working-capital requirements in India. The company reported no deviation or variation from its disclosed use of proceeds for the half year.
Know Unihealth Hospitals inside out
Results, valuation, peers and who's buying, in one view.
How much warrant funding did Unihealth Hospitals receive?
Unihealth Hospitals received Rs 8.31 crore by September 30, 2026, against the Rs 10.57 crore planned from 7,00,000 convertible warrants issued on May 2, 2025. The warrants were allotted to promoters at Rs 151 each after shareholder approval at an Extraordinary General Meeting on April 9, 2025.
The receipts comprised Rs 2.64 crore collected at allotment, representing 25% of the Rs 151 issue price on all 7,00,000 warrants, and Rs 5.66 crore received as the remaining 75% payment on conversion of 5,00,000 warrants. Unihealth Hospitals converted those 5,00,000 warrants into an equal number of equity shares by the reporting date.
The audit certificate records share allotments connected with warrant conversions on September 8, 2025, January 12, 2026 and April 10, 2026. Each resulting equity share had a face value of Rs 10 and a premium of Rs 141, matching the Rs 151 warrant issue price. The warrants may be converted into equal numbers of equity shares within 18 months from their May 2, 2025 allotment.
Where did Unihealth Hospitals use the received proceeds?
Unihealth Hospitals transferred the full Rs 8.31 crore received to UMC Hospitals, and UMC Hospitals utilized the entire amount by September 30, 2026. The disclosed object was capital expenditure, or capex, and working-capital requirements for hospitals in India.
The original allocation for UMC Hospitals was Rs 8.46 crore, while Rs 8.31 crore had been received for that object at the reporting date. The utilization statement records Rs 8.31 crore as utilized and nil as unutilized, meaning the amount received had been fully deployed even though the original allocation had not yet been fully funded.
G. P. Kapadia & Co., the statutory auditor, separately certified the transfer and end use. Its November 14, 2026 certificate says UMC Hospitals received Rs 8.31 crore out of the preferential-warrant proceeds and used that amount for capex and working-capital requirements by September 30, 2026; it does not provide a split between those two uses.
Got a follow-up? Ask IRIS
Did Unihealth Hospitals receive money for corporate purposes?
Unihealth Hospitals reported nil proceeds, nil utilization and nil unutilized funds against its Rs 2.11 crore allocation for company working capital and general corporate purpose at September 30, 2026. This was distinct from the Rs 8.31 crore received and used under the UMC Hospitals object.
The corporate-purpose allocation covers working-capital requirements, strategic initiatives, growth opportunities, marketing and brand building, general contingencies, fund-raising expenses and ordinary-course expenses. Unihealth Hospitals recorded no modification to this object, and the filing gives no timetable for receiving or deploying proceeds against it.
The Rs 10.57 crore overall planned raise exceeded the Rs 8.31 crore received by Rs 2.27 crore at the half-year end. The filing identifies 5,00,000 converted warrants out of 7,00,000 originally allotted, leaving 2,00,000 warrants unconverted as of September 30, 2026, based on those disclosed figures.
Was there any deviation in Unihealth Hospitals' use of funds?
Unihealth Hospitals reported no deviation or variation in utilization of the preferential-issue proceeds for the half year ended September 30, 2026. It also reported no change to either original object, no shareholder approval for a revised object and no audit committee or auditor comments on a deviation.
The disclosure was made under Regulation 32 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015. Unihealth Hospitals filed the statement with the National Stock Exchange of India on November 14, 2026, after its Audit Committee reviewed it and its Board took it on record on the same date.
The company marked a monitoring agency as not applicable for the May 2, 2025 preferential issue. G. P. Kapadia & Co. certified the utilization after reviewing the company’s documents, statements, books of account and other relevant information, and issued its certificate on November 14, 2026.
What remains under Unihealth Hospitals' warrant issue?
Unihealth Hospitals had 2,00,000 warrants not converted by September 30, 2026, based on the 7,00,000 warrants allotted and 5,00,000 warrants converted. The source does not state whether the remaining warrants were converted after that date or specify a conversion schedule.
The warrant terms permit conversion within 18 months from May 2, 2025. The remaining conversion activity is therefore the disclosed mechanism through which further proceeds could be received, but the filing does not say how any later receipts would be allocated between the Rs 8.46 crore UMC Hospitals object and the Rs 2.11 crore corporate-purpose object.
Conclusion
Unihealth Hospitals reported complete deployment of the Rs 8.31 crore it had received from the preferential warrant issue by September 30, 2026. The full amount was transferred to UMC Hospitals and used for Indian hospital capex and working capital, while the Rs 2.11 crore corporate-purpose allocation had received and used no proceeds; the company reported no deviation from either stated object.
The next item to watch is the conversion of the 2,00,000 warrants that remained unconverted at the reporting date, within the 18-month conversion period from May 2, 2025. Later disclosures may show additional proceeds and clarify whether funds are directed to the remaining UMC Hospitals allocation or the corporate-purpose allocation.


